Jump to main content
Jump to site search

Issue 35, 2015
Previous Article Next Article

Electroconductive smart polyacrylamide–polypyrrole (PAC–PPY) hydrogel: a device for controlled release of risperidone

Author affiliations

Abstract

Risperidone is a widely used antipsychotic drug for the treatment of schizophrenia and bipolar disorder. This paper discusses the preparation and use of a drug loaded electro-conductive hydrogel based on polyacrylamide and polypyrrole in the form of cylindrical devices to confer electro-actuable properties and also controlled release of the drug risperidone. The variation in the swelling and oxidation state of the material induced physical and chemical changes in the conducting polymer network. The electro-liberation process was optimized by tuning the properties of the composite. The hydrogel was characterized by various microscopic and spectroscopic analyses, swelling kinetics, and also network parameters. In vitro drug release studies were carried out in 0.1 N HCl and a phosphate buffer using dissolution apparatus with stirring. Cytotoxic results on HepG2 and C6 cells supported the biocompatibility of the hydrogel. A model was proposed for an implantable drug delivery device, where the dose could be adjusted by external signaling.

Graphical abstract: Electroconductive smart polyacrylamide–polypyrrole (PAC–PPY) hydrogel: a device for controlled release of risperidone

Back to tab navigation

Supplementary files

Article information


Submitted
26 Feb 2015
Accepted
10 Mar 2015
First published
10 Mar 2015

RSC Adv., 2015,5, 27665-27673
Article type
Paper

Electroconductive smart polyacrylamide–polypyrrole (PAC–PPY) hydrogel: a device for controlled release of risperidone

S. Saha, P. Sarkar, M. Sarkar and B. Giri, RSC Adv., 2015, 5, 27665
DOI: 10.1039/C5RA03535J

Social activity

Search articles by author

Spotlight

Advertisements